atractylenolide iii has been researched along with Asthenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Li, C; Liu, Z; Wang, L; Zhang, L; Zhu, C | 1 |
1 other study(ies) available for atractylenolide iii and Asthenia
| Article | Year |
|---|---|
Atractylenolide III reduces NLRP3 inflammasome activation and Th1/Th2 imbalances in both in vitro and in vivo models of asthma.
Topics: Animals; Asthenia; Cell Line; Disease Models, Animal; Humans; Inflammasomes; Lactones; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Sesquiterpenes; Th1 Cells; Th2 Cells | 2020 |